Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Michel, Burcklen"'
Autor:
Belén Valenzuela, Per Olsson Gisleskog, Italo Poggesi, Tatiana Sidorenko, Michel Burcklen, Hilke Kracker, Juan Jose Pérez‐Ruixo
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 10, Pp 1294-1304 (2022)
Abstract The efficacy of ponesimod and teriflunomide for the treatment of relapsing multiple sclerosis (MS) was compared in a randomized phase III trial. This study explores the exposure‐response (E‐R) relationships of efficacy end points (annual
Externí odkaz:
https://doaj.org/article/531afc9bc7ca4e63b7b43fe2aa37c10f
Autor:
Mark S, Freedman, Carlo, Pozzilli, Eva Kubala, Havrdova, Alexandre, Lemle, Michel, Burcklen, Anna, Larbalestier, Brian, Hennessy, Tatiana, Sidorenko, Andrea, Vaclavkova, Tomas, Olsson
Publikováno v:
Neurology. 99:e762-e774
ObjectiveTo evaluate the dose-response relationship of 10, 20, and 40 mg ponesimod and long-term efficacy and safety of ponesimod 20 mg using an analysis of combined data from the phase 2 Core and Extension studies in patients with relapsing-remittin
Autor:
Michel Burcklen, Tatiana Scherz, Belén Valenzuela, Per Olsson Gisleskog, Italo Poggesi, Juan Jose Perez-Ruixo
Publikováno v:
Clinical Pharmacokinetics. 60:1227-1237
Ponesimod is a sphingosphine-1-phosphate receptor modulator being developed for the treatment of multiple sclerosis. The effects of disease-modifying treatments on magnetic resonance imaging (MRI) lesions in relapsing multiple sclerosis accurately pr
Publikováno v:
Neurology. 99:S41.2-S41
ObjectiveWe describe Vivacity-MG3. our pivotal Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Nipocalimab Administered to Adults With gMG
Autor:
Andrea Vaclavkova, Paul-Gunther Sator, Péter Holló, Daniele D'Ambrosio, Sergio Chimenti, Petr Arenberger, Mylene Stefani, Michel Burcklen
Publikováno v:
The Lancet. 384:2036-2045
We assessed the efficacy, safety, and tolerability of ponesimod, an oral, selective, reversible modulator of sphingosine 1-phosphate receptor 1, in patients with moderate to severe chronic plaque psoriasis.Between Sept 22, 2010, and Oct 24, 2012, pat
Autor:
Elizabeth Blée, Jürgen Ehlting, Benoît Boachon, Michel Burcklen, Jean-Jacques Bessoule, Dimitri Heintz, Marina Le Guédard, Abdulsamie Hanano, Ivo Feussner, Cornelia Herrfurth
Publikováno v:
Plant Physiology
Plant Physiology, American Society of Plant Biologists, 2014, 166 (1), pp.109-124. ⟨10.1104/pp.114.245316⟩
Plant Physiology, American Society of Plant Biologists, 2014, 166 (1), pp.109-124
Plant Physiology, American Society of Plant Biologists, 2014, 166 (1), pp.109-124. ⟨10.1104/pp.114.245316⟩
Plant Physiology, American Society of Plant Biologists, 2014, 166 (1), pp.109-124
Contrasting with the wealth of information available on the multiple roles of jasmonates in plant development and defense, knowledge about the functions and the biosynthesis of hydroxylated oxylipins remains scarce. By expressing the caleosin RESPONS
Autor:
Michel Burcklen, Abdulsamie Hanano, Anabella Ivancich, Mathilde Louwagie, Martine Flenet, Elizabeth Blée, Jérôme Garin
Publikováno v:
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2008, 281, pp.33140-33151
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2008, 281, pp.33140-33151
A growing body of evidence indicates that phytooxylipins play important roles in plant defense responses. However, many enzymes involved in the biosynthesis of these metabolites are still elusive. We have purified one of these enzymes, the peroxygena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55a6d4962e302bd66de866750229334
https://hal.archives-ouvertes.fr/hal-00341938
https://hal.archives-ouvertes.fr/hal-00341938
Autor:
Valenzuela, Belén1 (AUTHOR) BValenz2@ITS.JNJ.com, Olsson Gisleskog, Per2 (AUTHOR), Poggesi, Italo3 (AUTHOR), Sidorenko, Tatiana4 (AUTHOR), Burcklen, Michel4 (AUTHOR), Kracker, Hilke4 (AUTHOR), Pérez‐Ruixo, Juan Jose1 (AUTHOR)
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Oct2022, Vol. 11 Issue 10, p1294-1304. 11p.
Publikováno v:
Neurology; 12/5/2022 Suppl 2, Vol. 99, pS41-S41, 1p
Publikováno v:
Multiple Sclerosis Journal; Oct2022 Suppl 3, Vol. 28, p984-1017, 34p